ACHN-490, a Neoglycoside with Potent In Vitro Activity against Multidrug-Resistant Klebsiella pneumoniae Isolates

Andrea Endimiani, Kristine M. Hujer, Andrea M. Hujer, Eliana S. Armstrong, Yuvraj Choudhary, James B. Aggen, and Robert A. Bonomo
Antimicrobial Agents and Chemotherapy, October 2009, p. 4504-4507, Vol. 53, No. 10

Access this publication @ aac.asm.org

Synthesis, Structure, and in vitro Activity of the Neoglycoside ACHN-490

James B. Aggen, Eliana S. Armstrong, Adam A. Goldblum, Paola Dozzo, Martin S. Linsell, Micah J. Gliedt, Darin J. Hildebrandt, Lee Ann Feeney,Aya Kubo, Rowena D. Matias, Sara Lopez, Marcela Gomez, Kenneth B. Wlasichuk, Raymond Diokno, George H. Miller, Heinz E. Moser
Achaogen, Inc.
ICAAC 2009, poster # F1-840

Download poster as PDF 

The Bactericidal Activity of the Neoglycoside ACHN-490 Against Aminoglycoside-Resistant Bacteria

Gary Zurenko, Douglas Stapert, Mary Knechtel, Nanette Nichols, Dean Shinabarger, Eliana S. Armstrong, James B. Aggen, Lee Ann Feeney, Aya Kubo, Rowena D. Matias, George H. Miller
Micromyx, Achaogen Inc.
ICAAC 2009, poster # F1-841

Download poster as PDF